<DOC>
	<DOCNO>NCT00283192</DOCNO>
	<brief_summary>The primary outcome FAST ( randomize double-blinded , placebo control , trial effect sertraline vs. placebo reduce incidence severity hot flush healthy woman ) determine 6 week treatment sertraline ( 50mg daily 2 week , follow 100mg per day 4 week , tolerate ) result great reduction hot flush score ( frequency * severity ) compare placebo among woman moderate severe hot flash . The secondary aim determine effect treatment sertraline quality life , sleep , sexual function , mood .</brief_summary>
	<brief_title>Flushes Sertraline Trial</brief_title>
	<detailed_description>The primary aim FAST determine 6 week treatment sertraline ( 50 mg daily 2 week , follow 100 mg per day 4 week , tolerate ) result great reduction hot flush score ( frequency x severity ) , frequency severity compare placebo among woman moderate severe hot flush . The Secondary Aims : To determine effect treatment sertraline quality life , sleep , sexual function , mood , cognitive function . To determine modify , short version sexual function instrument valid .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Age 40 – 60 year old Report &gt; 14 hot flush per week Willing randomize sertraline placebo Sign inform consent History bilateral oophorectomy Breast ovarian cancer Liver disease Kidney disease require dialysis History major depression ( reported history depression require therapy , hospitalization depression , take antidepressant drug , history suicide attempt ) History bipolar affective disorder ( reported history bipolar disorder require therapy , medication , hospitalize bipolar disorder ) Seizure disorder History hypersensitivity sertraline SSRIs Pregnancy breast feed Any medical psychiatric condition , investigator ’ opinion , would preclude participant adhere protocol complete trial ; No estrogen progestins 3 month prior screen enrollment Selective estrogen receptor modulators ( SERMS ) The following medication : clonidine , gabapentin , tricyclic antidepressant , monoamine oxidase ( MAO ) inhibitor , selective serotonin reuptake inhibitor ( SSRIs ) , megesterol , oral contraceptive , androgen ; medication list Pfizer Pharmaceutical drug insert “ contraindicate ”</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Menopausal Symptoms</keyword>
	<keyword>Hot flash</keyword>
</DOC>